UK scientists to make a million potential COVID-19 vaccines before proof

Singapore News News

UK scientists to make a million potential COVID-19 vaccines before proof
Singapore Latest News,Singapore Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

A million doses of a potential COVID-19 vaccine being developed by British scientists are already being manufactured and will be available by September, even before trials prove whether the shot is effective, the team said on Friday.

FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19, better known as the coronavirus linked to the Wuhan outbreak, shared with Reuters on February 18, 2020. NEXU Science Communication/via REUTERS

“The aim is to have at least a million doses by around about September, when we also hope to have efficacy results.” Hill’s team said they plan to start safety and then mid-stage efficacy trials of their potential COVID-19 vaccine in adults aged between 18 and 55 within weeks. They acknowledged that many other research teams worldwide were also working on potential vaccines, with only a proportion likely to be fully successful.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

106-year-old British woman beats COVID-19106-year-old British woman beats COVID-19A 106-year-old British woman beats COVID-19. Connie Titchen, from Birmingham in central England, battled the virus for just under three weeks and was given a clean bill of health by medics. GuyReuters reports
Read more »

Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI.
Read more »

A desperate scramble as COVID-19 families vie for access to plasma therapyA desperate scramble as COVID-19 families vie for access to plasma therapyEven as efforts ramp up to collect blood plasma from the first survivors of coronavirus, chances of procuring treatment appear to depend on geography, social-media savvy, and the willingness of physicians.
Read more »

A New Frontier for Self-Love—And Sex Toys—in the Time of COVID-19A New Frontier for Self-Love—And Sex Toys—in the Time of COVID-19With an uptick in conversation around female desire and a boom in female-led sex tech companies, one Vogue writer explores self-love in the time of COVID-19.
Read more »



Render Time: 2025-03-22 07:36:26